FDA
-
-
-
-
-
-
-
Ceribell Reports Fourth Quarter and Full Year 2025 Financial Results
-
-
-
-
-
-
-
Ceribell (CBLL) PT Raised to $29 at TD Cowen
-
-
-
-
-
-
-
Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
-
-
-
-
-
-
-
Ceribell to Participate in the Canaccord Genuity 45th Annual Growth Conference
-
-
-
-
-
-
-
Ceribell Receives FedRAMPĀ® High Authorization, Expanding Approval for Its AI-Powered Point-of-Care EEG Across Federal Healthcare Systems
-
-
-
-
-
-
-
Ceribell to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
-
-
-
-
-
-
-
Ceribell (CBLL): New Clinical Evidence Links Ceribell Point-of-Care EEG to Shorter Hospital Stays and Better Functional Outcomes Compared to Conventional EEG
-
326,369 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

